The use of subcutaneous omeprazole in the treatment of dyspepsia in palliative care patients

被引：18

作者：

Agar, M ^{[1
]}

Webster, R

Lacey, J

Donovan, B

Walker, A

机构：

[1] Calvary Hosp, Calvary Hlth Care Palliat Care Serv, Sydney, NSW, Australia

[2] Camden Hosp, Dept Palliat Care, Sydney, NSW, Australia

来源：

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 2004年 / 28卷 / 06期

关键词：

D O I：

10.1016/j.jpainsymman.2004.10.005

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页码：529 / 531

页数：3

共 9 条

[1]

*ASTRA ZENECA PTY, 2000, LOS INTR PROD INF

[2] Rectal absorption of omeprazole from suppository in humans [J].

Choi, MS ;

Chung, SJ ;

Shim, CK .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (08) :893-894

[3] IRREVERSIBLE INACTIVATION OF RAT GASTRIC (H+-K+)-ATPASE INVIVO BY OMEPRAZOLE [J].

IM, WB ;

BLAKEMAN, DP ;

DAVIS, JP .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 126 (01) :78-82

[4] Approaches to uninvestigated dyspepsia [J].

Jones, RH .

GUT, 2002, 50 :42-46

[5]

JONES W, 2003, B BOARD MESSAGE

[6] Pharmacologic management of gastroesophageal reflux disease. [J].

Ramakrishnan A. ;

Katz P.O. .

Current Gastroenterology Reports, 2002, 4 (3) :218-224

[7]

Schneider Jennifer J., 1997, Australian Journal of Hospital Pharmacy, V27, P29

[8]

WILLIAMS JG, 1985, ANAESTHESIA, V40, P242

[9]

Zylicz Z, 1998, J PAIN SYMPTOM MANAG, V15, P144

← 1 →